Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Yee Chao"'
Autor:
Li Yuan Bai, Yee Chao, Narikazu Boku, Taroh Satoh, Hyun Cheol Chung, Masahiro Tsuda, Won Ki Kang, Yoon-Koo Kang, Jae Yong Cho, Jen-Shi Chen, Ken Kato, Jong Gwang Kim, Yasuo Hamamoto, Keiko Minashi, Keun Wook Lee, Kun-Huei Yeh, Hiroki Sameshima, Keisho Chin, Sang Cheul Oh, Li-Tzong Chen, Kei Muro, Takaki Yoshikawa, Min Hee Ryu, Takao Tamura, Do Youn Oh, Satoshi Morita
Publikováno v:
Gastric Cancer
Background The phase 3 ATTRACTION-2 study demonstrated that nivolumab monotherapy was superior to placebo for patients with pretreated advanced gastric or gastroesophageal junction cancer, but early progression of tumors in some patients was of conce
Autor:
Fa-Yauh Lee, Yee Chao, Ming-Chih Hou, Tsung-Chieh Yang, Yi Hsiang Huang, Pei-Chang Lee, Yu Jen Chen, Chung-Pin Li
Publikováno v:
Journal of the Chinese Medical Association. 84:917-922
BACKGROUND The prevalence of esophagogastric varices (EGV) in patients with advanced pancreatic cancer is not rare. However, its clinical significance has never been investigated. This study was aimed to explore the clinical implication and outcomes
Autor:
Yee Chao, Kun Han Lee, Chun Chi Lin, Hao Wei Teng, Hung Hsin Lin, Jeng Kai Jiang, Shih Ching Chang, Wei Shone Chen, Sheng Chieh Huang, Shung Haur Yang, Huann Sheng Wang, Hou Hsuan Cheng, Yuan Tzu Lan
Publikováno v:
British Journal of Cancer. 125:816-825
Background Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal cancers. We aimed to examine the efficacy of anti-epidermal
Autor:
Kazuyoshi Ohkawa, Erluo Chen, Ho Yeong Lim, Yee Chao, Tatsuya Yamashita, Masayuki Kurosaki, Ann-Lii Cheng, Naoki Morimoto, Baek Yeol Ryoo, Abby B. Siegel, Kyung Hun Lee, Masatoshi Kudo, Sadahisa Ogasawara, Thomas Yau
Publikováno v:
Liver Cancer, Vol 10, Iss 3, Pp 275-284 (2021)
Liver Cancer
Liver Cancer
Introduction: KEYNOTE-240 investigated the efficacy and safety of pembrolizumab plus best supportive care (BSC) in sorafenib-treated patients with advanced hepatocellular carcinoma (HCC). Results for the subgroup of patients from Asia are described.
Autor:
Li-Tzong Chen, Taroh Satoh, Keisho Chin, Takaki Yoshikawa, Yee Chao, Masahiro Tsuda, Hyun Cheol Chung, Keun Wook Lee, Keiko Minashi, Min Hee Ryu, Jong Gwang Kim, Yoon-Koo Kang, Jae Yong Cho, Ken Kato, Narikazu Boku, Won Ki Kang, Takao Tamura, Do Youn Oh, Kun-Huei Yeh, Li Yuan Bai, Yasuo Hamamoto, Taihei Nishiyama, Jen-Shi Chen, Kei Muro, Sang Cheul Oh
Publikováno v:
Gastric Cancer
Background ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with ≥ 2 chemotherapy regimens. However, its long-term efficacy and outcome of treatment beyond progressi
Autor:
Yu Hui Su, Cheng Yi Wei, Yee Chao, Ping Hsien Chen, Chien Wei Su, Gar Yang Chau, Jaw Ching Wu, Ming Chih Hou, Rheun Chuan Lee, Chung Yu Chang, Yi Hsiang Huang
Publikováno v:
Journal of the Chinese Medical Association. 84:136-143
Patients with hepatocellular carcinoma (HCC) and with a single tumor2 cm in size are classified as having Barcelona Clinic Liver Cancer (BCLC) stage 0 HCC. We aimed to investigate the role of the albumin-bilirubin (ALBI) grade in predicting outcomes
Autor:
Kuo Hung Huang, Li Wen Hsu, Su Shun Lo, Yee Chao, Chew Wun Wu, Wen Liang Fang, Anna Fen Yau Li, Yi Ming Shyr, Ming Huang Chen
Publikováno v:
Aging (Albany NY)
To date, few reports have investigated the genetic alterations and clinicopathological features in gastric cancer (GC) according to sex. In total, 2673 GC patients receiving curative surgery were enrolled. Among the 2673 GC patients, 1979 (74.0%) pat
Autor:
Baek-Yeol Ryoo, Ho Yeong Lim, Marcelo Garrido, Sadahisa Ogasawara, Yee Chao, Erluo Chen, Ann-Lii Cheng, Josephine M. Norquist, Thomas Yau, Bruno Daniele, Masatoshi Kudo, Valeriy Breder, Richard S. Finn, Stephen L. Chan, Philippe Merle, Julien Edeline, Andrew X. Zhu, Amit S. Kulkarni, Abby B. Siegel, Mohamed Bouattour
Publikováno v:
Cancer. 127:865-874
Background Health-related quality of life (HRQoL) is an important outcome measure and prognostic indicator in hepatocellular carcinoma (HCC). KEYNOTE-240 (NCT02702401) assessed the efficacy and safety of pembrolizumab plus best supportive care (BSC)
Autor:
Tien Hua Chen, Yee Chao, Wei Shone Chen, Huann Sheng Wang, Jeng Kai Jiang, Sheng Chieh Huang, Chun Chi Lin, Cheng Yuan Hsia, Hung Hsin Lin, Shih Ching Chang, Hao Wei Teng, Shu Cheng Chou, Yuan Tzu Lan, Hao Jan Lei, Shung Haur Yang, Gar Yang Chau, Hou Hsuan Cheng
Publikováno v:
Journal of Gastrointestinal Surgery. 25:650-661
The effects of primary tumor location on colorectal liver metastasis (CRLM) and post-hepatic-metastasectomy overall survival (OS) are controversial. This study evaluated the difference in post-hepatic-metastasectomy OS among right-sided colon, left-s
Autor:
Anna Fen-Yau Li, Han-Fang Cheng, Yee Chao, Wen-Liang Fang, Ming-Huang Chen, Su Shun Lo, Chew-Wun Wu, Kuo Hung Huang, Chien-Hsing Lin, Yi-Ming Shyr
Publikováno v:
International Surgery. 106:39-47
Objective The Lauren classification is an important histologic classification of gastric cancer (GC) with different biological behaviors between histologic types. Background To date, there are few reports on the genetic alterations and survival diffe